TrialAntimicrobial agents and chemotherapy2014

Multicenter, double-blind, randomized, phase II trial to assess the safety and efficacy of ceftolozane-tazobactam plus metronidazole compared with meropenem in adult patients with complicated intra-abdominal infections.

Christopher Lucasti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.